Next Article in Journal
Mercury Levels in an Urban Pregnant Population in Durham County, North Carolina
Next Article in Special Issue
The Dynamics of Norovirus Outbreak Epidemics: Recent Insights
Previous Article in Journal
Recent Contributions of Air- and Biomarkers to the Control of Secondhand Smoke (SHS): A Review
Previous Article in Special Issue
Environmental Monitoring and Analysis of Faecal Contamination in an Urban Setting in the City of Bari (Apulia Region, Italy): Health and Hygiene Implications
Int. J. Environ. Res. Public Health 2011, 8(3), 683-697; doi:10.3390/ijerph8030683
Review

Control of Advanced Cancer: The Road to Chronicity

*  and
Received: 28 December 2010; in revised form: 28 January 2011 / Accepted: 11 February 2011 / Published: 1 March 2011
(This article belongs to the Special Issue Recent Advances in Public Health)
View Full-Text   |   Download PDF [175 KB, uploaded 19 June 2014]
Abstract: Despite the recent trend toward a slight decrease in age-adjusted cancer mortality in some countries, crude mortality rates will continue to increase, driven by the demographic shift towards an aged population. Small molecules (small molecules and biologics) are not only a new therapeutic acquisition, but the tools of a more fundamental transition: the transformation of cancer from a rapidly fatal disease into a chronic condition. Antibodies and cancer vaccines can be used for a long time, even beyond progressive disease, and in aged patients, usually unfit for more aggressive conventional treatments. However, this transition to chronicity will require novel developmental guidelines adequate to this kind of drugs, for which optimal dose is not usually the maximal tolerated dose, pharmacokinetics does not define treatment schedule, and tumor shrinkage is not a good correlate of survival. The ongoing cancer immunotherapy program (including several monoclonal antibodies and therapeutic vaccines) at the Centre of Molecular Immunology can illustrate the issues to be addressed, both biological and social, along the path to transform advanced cancer into a chronic non-communicable disease compatible with years of quality life.
Keywords: advanced cancer; chronic treatment; small molecules; biotechnology advanced cancer; chronic treatment; small molecules; biotechnology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Lage, A.; Crombet, T. Control of Advanced Cancer: The Road to Chronicity. Int. J. Environ. Res. Public Health 2011, 8, 683-697.

AMA Style

Lage A, Crombet T. Control of Advanced Cancer: The Road to Chronicity. International Journal of Environmental Research and Public Health. 2011; 8(3):683-697.

Chicago/Turabian Style

Lage, Agustin; Crombet, Tania. 2011. "Control of Advanced Cancer: The Road to Chronicity." Int. J. Environ. Res. Public Health 8, no. 3: 683-697.


Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert